Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two?

作     者：Stanislav Suskovic Mitja Kosnik Mitja Lainscak 

作者机构：Department for Clinical Audit University Clinic for Respiratory and Allergic Diseases Golnik University Clinic for Respiratory and Allergic Diseases Golnik Division of Cardiology University Clinic for Respiratory and Allergic Diseases Golnik Applied Cachexia Research Department of Cardiology Charité Campus Virchow-Klinikum 

出 版 物：《World Journal of Cardiology》 (世界心脏病学杂志（英文版）（电子版）)

年 卷 期：2010年第2卷第10期

页      面：305-307页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Heart failure Chronic obstructive pulmonary disease Spirometry β blocker Inflammation 

摘      要：A combination of chronic obstructive pulmonary disease (COPD) and heart failure (HF) is common yet it is inadequately and rarely recognized. Because of the similar clinical manifestations, comorbidity is frequently not considered and appropriate diagnostic tests are not performed. It is very important that a combination of COPD and HF is recognized as these patients have a worse prognosis than patients with an individual disease. When present, COPD should not prevent the use of life-saving therapy in patients with HF, particularly β-blockers. Despite clear evidence of the safety and tolerability of cardioselective β-blockers in COPD patients, these drugs remain grossly underprescribed and underdosed. Routine spirometry and echocardiography in HF and COPD patients, respectively, is therefore warranted to improve current clinical practice.